Essential Medical has announced that more than 1,000 Manta large bore vascular closure devices have been successfully deployed globally. To meet the growing demands of the large bore closure market, Essential Medical is also increasing their production capacity with a new facility located in Exton, USA.
Manta is a CE marked vascular closure device designed to close punctures ranging from 10F to 24F at femoral arterial access sites after cardiac catheterisation procedures such as transcatheter aortic valve implantation, endovascular treatment of abdominal aortic aneurysms, ventricular assist, and balloon aortic valvuloplasty. Manta is an investigational device in the USA and Canada.
Closure of large bore femoral access sites has been associated with significant morbidity including long times to achieve haemostasis, extended procedure time, need for a vascular surgeon in the catheterisation lab, delayed ambulation, higher rate of complications and higher total cost of care. Manta was designed to address the complexities of closing large punctures in high-pressure vessels utilising novel closure technology. The device’s deployment is designed to provide immediate haemostasis in order to reduce complications associated with large bore closure.